235 related articles for article (PubMed ID: 33097309)
1. [Erlotinib-induced scarring alopecia with a folliculitis decalvans-like presentation].
Dervout C; Chiappa AM; Fleuret C; Plantin P; Acquitter M
Ann Dermatol Venereol; 2020 Dec; 147(12):848-852. PubMed ID: 33097309
[TBL] [Abstract][Full Text] [Related]
2. Successful Treatment with Fusidic Acid in a Patient with Folliculitis Decalvans.
Pimenta R; Borges-Costa J
Acta Dermatovenerol Croat; 2019 Mar; 27(1):49-50. PubMed ID: 31032795
[TBL] [Abstract][Full Text] [Related]
3. EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines.
Nowaczyk J; Fret K; Kaminska-Winciorek G; Rudnicka L; Czuwara J
Anticancer Drugs; 2023 Sep; 34(8):942-948. PubMed ID: 36708507
[TBL] [Abstract][Full Text] [Related]
4. Folliculotropic Cutaneous Metastases and Lymphangitis Carcinomatosa: When Cutaneous Metastases of Breast Carcinoma Are Mistaken for Cutaneous Infections.
Paolino G; Panetta C; Didona D; Donati M; Donati P
Acta Dermatovenerol Croat; 2016 Jun; 24(2):154-7. PubMed ID: 27477179
[TBL] [Abstract][Full Text] [Related]
5. Folliculitis decalvans-like pustular plaques on the limbs sparing the scalp.
Yang A; Hannaford R; Kossard S
Australas J Dermatol; 2020 Feb; 61(1):54-56. PubMed ID: 31621894
[TBL] [Abstract][Full Text] [Related]
6. [Dapsone treatment of folliculitis decalvans].
Paquet P; Piérard GE
Ann Dermatol Venereol; 2004 Feb; 131(2):195-7. PubMed ID: 15026749
[TBL] [Abstract][Full Text] [Related]
7. Folliculitis spinulosa decalvans: successful therapy with dapsone.
Kunte C; Loeser C; Wolff H
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 2):891-3. PubMed ID: 9810924
[TBL] [Abstract][Full Text] [Related]
8. Resolution of folliculitis decalvans with medical honey.
Yeh JE; Hartman RI; Xu J; Hoang M; Yasuda MR
Dermatol Online J; 2019 Aug; 25(8):. PubMed ID: 31553869
[TBL] [Abstract][Full Text] [Related]
9. Treatment of folliculitis decalvans using intensity-modulated radiation via tomotherapy.
Elsayad K; Kriz J; Haverkamp U; Plachouri KM; Jeskowiak A; Sunderkötter C; Eich HT
Strahlenther Onkol; 2015 Nov; 191(11):883-8. PubMed ID: 26400479
[TBL] [Abstract][Full Text] [Related]
10. Folliculitis spinulosa decalvans: an uncommon entity within the keratosis pilaris atrophicans spectrum.
Di Lernia V; Ricci C
Pediatr Dermatol; 2006; 23(3):255-8. PubMed ID: 16780474
[TBL] [Abstract][Full Text] [Related]
11. Folliculitis decalvans associated with erlotinib.
Hoekzema R; Drillenburg P
Clin Exp Dermatol; 2010 Dec; 35(8):916-8. PubMed ID: 20456379
[No Abstract] [Full Text] [Related]
12. [Pityriasis amiantacea and folliculitis decalvans : An unusual manifestation associated with antitumor necrosis factor-α therapy].
Zamperetti M; Zelger B; Höpfl R
Hautarzt; 2017 Dec; 68(12):1007-1010. PubMed ID: 29038892
[TBL] [Abstract][Full Text] [Related]
13. A case of folliculitis decalvans involving the beard, face and nape.
Karakuzu A; Erdem T; Aktas A; Atasoy M; Gulec AI
J Dermatol; 2001 Jun; 28(6):329-31. PubMed ID: 11476113
[TBL] [Abstract][Full Text] [Related]
14. Intravenous human immunoglobulin for treatment of folliculitis decalvans.
Ismail N; Ralph N; Murphy G
J Dermatolog Treat; 2015 Oct; 26(5):471-2. PubMed ID: 25798695
[TBL] [Abstract][Full Text] [Related]
15. Markers in the epidermal growth factor receptor pathway and skin toxicity during erlotinib treatment.
Tan AR; Steinberg SM; Parr AL; Nguyen D; Yang SX
Ann Oncol; 2008 Jan; 19(1):185-90. PubMed ID: 17878175
[TBL] [Abstract][Full Text] [Related]
16. Successful Management of Folliculitis Decalvans.
Kashikar Y; Saoji V; Madke B; Chandak MS; Meghe S
Cureus; 2024 Jan; 16(1):e52881. PubMed ID: 38406166
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Tumour Necrosis Factor-α Antagonists for Folliculitis Decalvans: A Retrospective Case-series Pilot Study.
Dupont A; Eyraud A; Milpied B; De Bataille S; Cassassa E; Darrigade AS; Barnetche T; Doutre MS; Matard B; Beylot-Barry M; Seneschal J
Acta Derm Venereol; 2023 Mar; 103():adv3713. PubMed ID: 36987539
[TBL] [Abstract][Full Text] [Related]
18. Folliculitis decalvans and tufted folliculitis are specific infective diseases that may lead to scarring, but are not a subset of central centrifugal scarring alopecia.
Powell J; Dawber RP
Arch Dermatol; 2001 Mar; 137(3):373-4. PubMed ID: 11255348
[No Abstract] [Full Text] [Related]
19. Folliculitis decalvans.
Otberg N; Kang H; Alzolibani AA; Shapiro J
Dermatol Ther; 2008; 21(4):238-44. PubMed ID: 18715292
[TBL] [Abstract][Full Text] [Related]
20. Doxycycline for prevention of erlotinib-induced rash in patients with non-small-cell lung cancer (NSCLC) after failure of first-line chemotherapy: A randomized, open-label trial.
Deplanque G; Gervais R; Vergnenegre A; Falchero L; Souquet PJ; Chavaillon JM; Taviot B; Fraboulet G; Saal H; Robert C; Chosidow O;
J Am Acad Dermatol; 2016 Jun; 74(6):1077-85. PubMed ID: 26946985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
